Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.7861/clinmed.2020-0228

http://scihub22266oqcxt.onion/10.7861/clinmed.2020-0228
suck pdf from google scholar
32423903!7385762!32423903
unlimited free pdf from europmc32423903    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid32423903      Clin+Med+(Lond) 2020 ; 20 (4): e76-e81
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Thrombotic risk in COVID-19: a case series and case-control study #MMPMID32423903
  • Stoneham SM; Milne KM; Nuttall E; Frew GH; Sturrock BR; Sivaloganathan H; Ladikou EE; Drage S; Phillips B; Chevassut TJ; Eziefula AC
  • Clin Med (Lond) 2020[Jul]; 20 (4): e76-e81 PMID32423903show ga
  • BACKGROUND: A possible association between COVID-19 infection and thrombosis, either as a direct consequence of the virus or as a complication of inflammation, is emerging in the literature. Data on the incidence of venous thromboembolism (VTE) are extremely limited. METHODS: We describe three cases of thromboembolism refractory to heparin treatment, the incidence of VTE in an inpatient cohort, and a case-control study to identify risk factors associated with VTE. RESULTS: We identified 274 confirmed (208) or probable (66) COVID-19 patients. 21 (7.7%) were diagnosed with VTE. D-dimer was elevated in both cases (confirmed VTE) and controls (no confirmed VTE) but higher levels were seen in confirmed VTE cases (4.1 vs 1.2 mug/mL, p<0.001). CONCLUSION: Incidence of VTE is high in patients hospitalised with COVID-19. Urgent clinical trials are needed to evaluate the role of anticoagulation in COVID-19. Monitoring of D-dimer and anti-factor Xa levels may be beneficial in guiding management.
  • |*Betacoronavirus[MESH]
  • |Aged[MESH]
  • |Aged, 80 and over[MESH]
  • |Anticoagulants/therapeutic use[MESH]
  • |Biomarkers/blood[MESH]
  • |COVID-19[MESH]
  • |Case-Control Studies[MESH]
  • |Coronavirus Infections/blood/*complications[MESH]
  • |Female[MESH]
  • |Fibrin Fibrinogen Degradation Products/*metabolism[MESH]
  • |Heparin, Low-Molecular-Weight/therapeutic use[MESH]
  • |Humans[MESH]
  • |Incidence[MESH]
  • |Male[MESH]
  • |Middle Aged[MESH]
  • |Pandemics[MESH]
  • |Pneumonia, Viral/blood/*complications[MESH]
  • |Retrospective Studies[MESH]
  • |Risk Factors[MESH]
  • |SARS-CoV-2[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box